Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,307.20 -80.41 -0.52%
S&P 500 1,655.35 -13.81 -0.83%
Nasdaq 3,463.30 -38.82 -1.11%
Ticker Volume Price Price Delta
STOXX 50 2,835.01 +13.36 0.47%
FTSE 100 6,840.27 +36.40 0.53%
DAX 8,530.89 +58.69 0.69%
Ticker Volume Price Price Delta
Nikkei 15,627.30 +246.24 1.60%
Hang Seng 23,261.10 -105.29 -0.45%
S&P/ASX 200 5,165.37 -14.69 -0.28%
  • Fund Type: FCP
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

Carnegie Fund - Medical Sub-Fund

+ Add to Watchlist

CARMEII:LX

535.99 NOK 4.91 0.92%

As of 00:59:30 ET on 05/22/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Carnegie Fund - Medical Sub-Fund (CARMEII)

Year To Date: +23.54% 3-Month: +12.77% 3-Year: +14.99% 52-Week Range: 405.03 - 538.33
1-Month: +2.83% 1-Year: +30.52% 5-Year: +9.47% Beta vs LUXXX: 0.55

Mutual Fund Chart for CARMEII

No chart data available.
  • CARMEII:LX 535.99
  • 1M
  • 1Y
Interactive CARMEII Chart

Previous Close

Fund Profile & Information for CARMEII

Carnegie Fund - Medical Sub-Fund is an FCP incorporated in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests globally in equities of companies operating in the pharmaceutical, biotechnology and medical technology sectors.

Inception Date: 12-18-2000 Telephone: 352-40-40-30-1
Managers: ANGELICA FATOUROS
Web Site: www.carnegieam.com

Fundamentals for CARMEII

NAV (on 2013-05-22) 535.99
Assets (M) (on 2013-04-30) 460.37
Fund Leveraged N
Minimum Investment 1,000,000.00
Minimum Subsequent Investment -

Dividends for CARMEII

No dividends reported

Fees & Expenses for CARMEII

Front Load 3.00
Back Load 0.50
Current Mgmt Fee 0.70
Redemption Fee 0.50
12b1 Fee -
Expense Ratio -

Top Fund Holdings for CARMEII

Filing Date: 04/30/2013
Name Position Value % of Total
Pfizer Inc 1,672,359 37,884,443 8.229%
Roche Holding AG 177,900 33,702,045 7.321%
Novartis AG 424,216 23,808,023 5.171%
Gilead Sciences Inc 572,832 21,983,921 4.775%
Celgene Corp 230,387 20,680,118 4.492%
Merck & Co Inc 556,200 20,223,530 4.393%
Fresenius SE & Co KGaA 189,882 17,991,320 3.908%
UnitedHealth Group Inc 369,300 16,758,765 3.640%
Carnegie Fund V - The Carnegie 108,460 16,629,107 3.612%
Novo Nordisk A/S 99,360 13,240,448 2.876%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil